Terms: = Pancreatic cancer AND MYH9, P35579, 4627, ENSG00000100345, DFNA17 AND Treatment
4 results:
1. CircSTX6 promotes pancreatic ductal adenocarcinoma progression by sponging miR-449b-5p and interacting with CUL2.
Meng L; Zhang Y; Wu P; Li D; Lu Y; Shen P; Yang T; Shi G; Chen Q; Yuan H; Ge W; Miao Y; Tu M; Jiang K
Mol Cancer; 2022 Jun; 21(1):121. PubMed ID: 35650603
[TBL] [Abstract] [Full Text] [Related]
2. 4H12, a Murine Monoclonal Antibody Directed against Myosin Heavy Chain-9 Expressed on Acinar Cell Carcinoma of Pancreas with Potential Therapeutic Application.
Balouchi-Anaraki S; Ahmadvand S; Safaei A; Ghaderi A
Iran Biomed J; 2021 Sep; 25(5):310-22. PubMed ID: 34425650
[TBL] [Abstract] [Full Text] [Related]
3. Eltrombopag to allow chemotherapy in a patient with myh9-related inherited thrombocytopenia and pancreatic cancer.
Paciullo F; Bury L; Gresele P
Int J Hematol; 2020 Nov; 112(5):725-727. PubMed ID: 32557126
[TBL] [Abstract] [Full Text] [Related]
4. Pharmacological activation of myosin II paralogs to correct cell mechanics defects.
Surcel A; Ng WP; West-Foyle H; Zhu Q; Ren Y; Avery LB; Krenc AK; Meyers DJ; Rock RS; Anders RA; Freel Meyers CL; Robinson DN
Proc Natl Acad Sci U S A; 2015 Feb; 112(5):1428-33. PubMed ID: 25605895
[TBL] [Abstract] [Full Text] [Related]
